Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5477 | 1552 | 44.2 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1857 | 5546 | PROLACTIN//PROLACTIN RECEPTOR//PHOSPHORYLATED PROLACTIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EVANS IMMUNOL | Address | 6 | 100% | 0% | 4 |
2 | HLTH SCI 304 | Address | 6 | 100% | 0% | 4 |
3 | LUPRON DEPOT | Author keyword | 4 | 67% | 0% | 4 |
4 | MOL MED INFECT DIS BIOMED SCI PATHOB | Address | 4 | 75% | 0% | 3 |
5 | THYMIC CELLULARITY | Author keyword | 4 | 75% | 0% | 3 |
6 | RHEUMATOL MOL IMMUNOL | Address | 4 | 29% | 1% | 12 |
7 | CELL BIOL MOL CYTOGENET | Address | 3 | 100% | 0% | 3 |
8 | GENES TRANSPLANTAT | Address | 3 | 100% | 0% | 3 |
9 | TARGET CELL SENSITIZATION | Author keyword | 3 | 100% | 0% | 3 |
10 | IMMUNE SEXUAL DIMORPHISM | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LUPRON DEPOT | 4 | 67% | 0% | 4 | Search LUPRON+DEPOT | Search LUPRON+DEPOT |
2 | THYMIC CELLULARITY | 4 | 75% | 0% | 3 | Search THYMIC+CELLULARITY | Search THYMIC+CELLULARITY |
3 | TARGET CELL SENSITIZATION | 3 | 100% | 0% | 3 | Search TARGET+CELL+SENSITIZATION | Search TARGET+CELL+SENSITIZATION |
4 | IMMUNE SEXUAL DIMORPHISM | 2 | 67% | 0% | 2 | Search IMMUNE+SEXUAL+DIMORPHISM | Search IMMUNE+SEXUAL+DIMORPHISM |
5 | IMMUNOENDOCRINOLOGY | 2 | 43% | 0% | 3 | Search IMMUNOENDOCRINOLOGY | Search IMMUNOENDOCRINOLOGY |
6 | NZB X NZW F1 MICE | 1 | 50% | 0% | 2 | Search NZB+X+NZW+F1+MICE | Search NZB+X+NZW+F1+MICE |
7 | P388 LEUKEMIA CELL LINE | 1 | 100% | 0% | 2 | Search P388+LEUKEMIA+CELL+LINE | Search P388+LEUKEMIA+CELL+LINE |
8 | REPRODUCTIVE IMMUNE INTERACTIONS | 1 | 100% | 0% | 2 | Search REPRODUCTIVE+IMMUNE+INTERACTIONS | Search REPRODUCTIVE+IMMUNE+INTERACTIONS |
9 | SUBSETS T CELLS | 1 | 100% | 0% | 2 | Search SUBSETS+T+CELLS | Search SUBSETS+T+CELLS |
10 | THYMIC STRUCTURE | 1 | 100% | 0% | 2 | Search THYMIC+STRUCTURE | Search THYMIC+STRUCTURE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LHRH RECEPTORS | 31 | 64% | 2% | 30 |
2 | NORMAL MALE MICE | 21 | 75% | 1% | 15 |
3 | PLASMODIUM CHABAUDI MALARIA | 14 | 57% | 1% | 17 |
4 | AUTO IMMUNITY | 12 | 52% | 1% | 16 |
5 | P815 MURINE MASTOCYTOMA | 11 | 100% | 0% | 6 |
6 | NONSTEROIDAL ANTIESTROGENS INHIBIT | 8 | 62% | 1% | 8 |
7 | RAT SPLEEN LYMPHOCYTES | 7 | 53% | 1% | 10 |
8 | ALLEVIATES DISEASE SEVERITY | 7 | 64% | 0% | 7 |
9 | ORAL CONTRACEPTIVE THERAPY | 7 | 64% | 0% | 7 |
10 | F1 MOUSE MODEL | 6 | 71% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Gonadal steroids and immunity | 1996 | 473 | 132 | 64% |
Estrogen Receptors in Immunity and Autoimmunity | 2011 | 58 | 85 | 61% |
Sex hormones and the immune response in humans | 2005 | 308 | 163 | 38% |
Gonadal steroids and humoral immunity | 2013 | 33 | 53 | 34% |
The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity | 2003 | 143 | 119 | 67% |
Sex affects immunity | 2012 | 89 | 155 | 33% |
The complex role of estrogens in inflammation | 2007 | 396 | 545 | 19% |
Sex-based differences in immune function and responses to vaccination | 2015 | 4 | 89 | 18% |
Sex hormones as immunomodulators in health and disease | 2001 | 173 | 68 | 53% |
The influence of sex and gender on the immune response | 2012 | 60 | 89 | 34% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EVANS IMMUNOL | 6 | 100% | 0.3% | 4 |
2 | HLTH SCI 304 | 6 | 100% | 0.3% | 4 |
3 | MOL MED INFECT DIS BIOMED SCI PATHOB | 4 | 75% | 0.2% | 3 |
4 | RHEUMATOL MOL IMMUNOL | 4 | 29% | 0.8% | 12 |
5 | CELL BIOL MOL CYTOGENET | 3 | 100% | 0.2% | 3 |
6 | GENES TRANSPLANTAT | 3 | 100% | 0.2% | 3 |
7 | IMMUNOL BRANISLAV JANKOVIC | 2 | 20% | 0.5% | 8 |
8 | PUBL HLTH PREVENT PHARMACOL | 2 | 29% | 0.3% | 5 |
9 | CELLULAR BIOL STEROID TOXICOL | 1 | 100% | 0.1% | 2 |
10 | MED RHEUMATOL 3 | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000238608 | EXPT RHEUMATOL NEUROENDOCRINOIMMUNOL//NEUROENDOCRINOIMMUNOL//MODIFIED RELEASE PREDNISONE |
2 | 0.0000162256 | UCLA MULTIPLE SCLEROSIS PROGRAM//MULTIPLE SCLEROSIS PROGRAM//POSTPARTUM ACTIVATION |
3 | 0.0000115867 | TAENIA CRASSICEPS//IMMUNOENDOCRINE//DPTO FISIOL BIOFIS NEUROCIENCIAS |
4 | 0.0000090574 | MOTHERS RHEUMAT DIS//PREGNANCY RHEUMAT DIS//LUPUS PREGNANCY |
5 | 0.0000090429 | EDWARD R MADIGAN 207//BIOACTIVE PROLACTIN//THYMUS |
6 | 0.0000086870 | BOLDENONE UNDECYLENATE//MOL INFECT MED MIMS//CELLULAR PATHOPHYSIOLOGY |
7 | 0.0000071551 | AUTOIMMUNE PROGESTERONE DERMATITIS//PREMENSTRUAL ASTHMA//PERIMENSTRUAL ASTHMA |
8 | 0.0000068966 | TRAUMA HEMORRHAGE//IMMUNE DEPRESSION//INVIVO HEMOREFLECTOMETER |
9 | 0.0000057524 | COPCORD//RHEUMATIC MUSCULOSKELETAL DISORDERS//COMMUNITY BASED EPIDEMIOL PREVENT TREATMENT RHE |
10 | 0.0000057328 | SEXUALLY TRANSMITTED VIRUS//MICHAEL DEGROOTE LEARNING DISCOVERY//HUMAN CERVIX |